Episode 518: Journal Club of 2nd-Gen Anti-VEGF Drugs, Povidone Iodine during Vitrectomy for Endophthalmitis, Racial and Ethnic Disparities in Retinal Disease, and Pegcetacoplan for Geographic Atrophy
Drs. Katherine Talcott, Akshay Thomas, and Sarwar Zahid join to discuss four recent publications in major ophthalmology journals:
Real-World Outcomes with Second Generation Injected Anti-VEGF Drugs (https://pubmed.ncbi.nlm.nih.gov/42717802/)
Povidone Iodine during Vitrectomy for Endophthalmitis (https://www.ovid.com/jnls/retinajournal/abstract/10.1097/iae.0000000000005006~adjunct-0025-povidone-iodine-irrigation-at-time-of?redirectionsource=fulltextview)
Racial and Ethnic Disparities in Retinal Disease (https://www.aaojournal.org/article/S0161-6420(26)00648-2/abstract)
Two-Year Real-World Outcomes of Pegcetacoplan for Geographic Atrophy (https://pubmed.ncbi.nlm.nih.gov/42727684/)
This episode was sponsored by Cited. Cited is PubMed meets Instagram Stories for retina specialists, free to download, made for hearing what your peers think about the latest research. Find it at https://apps.apple.com/us/app/cited-for-retina/id6764145960.
